219 related articles for article (PubMed ID: 16103363)
21. Experimental studies on the mechanism of glyceryl trinitrate-tolerance and dependence.
Axelsson KL; Ahlner J; Areskog NH; Andersson RG
Z Kardiol; 1986; 75 Suppl 3():28-9. PubMed ID: 3026103
[TBL] [Abstract][Full Text] [Related]
22. Explaining the phenomenon of nitrate tolerance.
Münzel T; Daiber A; Mülsch A
Circ Res; 2005 Sep; 97(7):618-28. PubMed ID: 16195486
[TBL] [Abstract][Full Text] [Related]
23. Cytochrome P-450 mediates bioactivation of organic nitrates.
Schröder H
J Pharmacol Exp Ther; 1992 Jul; 262(1):298-302. PubMed ID: 1352550
[TBL] [Abstract][Full Text] [Related]
24. Different effects of ascorbate deprivation and classical vascular nitrate tolerance on aldehyde dehydrogenase-catalysed bioactivation of nitroglycerin.
Wenzl MV; Wölkart G; Stessel H; Beretta M; Schmidt K; Mayer B
Br J Pharmacol; 2009 Apr; 156(8):1248-55. PubMed ID: 19254277
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of glyceryl trinitrate-induced vasodilation. I. Relationship between drug biotransformation, tissue cyclic GMP elevation and relaxation of rabbit aorta.
Brien JF; McLaughlin BE; Kobus SM; Kawamoto JH; Nakatsu K; Marks GS
J Pharmacol Exp Ther; 1988 Jan; 244(1):322-7. PubMed ID: 2826771
[TBL] [Abstract][Full Text] [Related]
26. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
[TBL] [Abstract][Full Text] [Related]
27. Effect of overexpression of human aldehyde dehydrogenase 2 in LLC-PK1 cells on glyceryl trinitrate biotransformation and cGMP accumulation.
D'Souza Y; Ji Y; Bennett BM
Br J Pharmacol; 2013 Feb; 168(4):978-87. PubMed ID: 22994391
[TBL] [Abstract][Full Text] [Related]
28. Bioactivation of nitroglycerin by purified mitochondrial and cytosolic aldehyde dehydrogenases.
Beretta M; Gruber K; Kollau A; Russwurm M; Koesling D; Goessler W; Keung WM; Schmidt K; Mayer B
J Biol Chem; 2008 Jun; 283(26):17873-80. PubMed ID: 18450747
[TBL] [Abstract][Full Text] [Related]
29. Vascular bioactivation of nitroglycerin by aldehyde dehydrogenase-2: reaction intermediates revealed by crystallography and mass spectrometry.
Lang BS; Gorren AC; Oberdorfer G; Wenzl MV; Furdui CM; Poole LB; Mayer B; Gruber K
J Biol Chem; 2012 Nov; 287(45):38124-34. PubMed ID: 22988236
[TBL] [Abstract][Full Text] [Related]
30. Potent inhibition of aldehyde dehydrogenase-2 by diphenyleneiodonium: focus on nitroglycerin bioactivation.
Neubauer R; Neubauer A; Wölkart G; Schwarzenegger C; Lang B; Schmidt K; Russwurm M; Koesling D; Gorren AC; Schrammel A; Mayer B
Mol Pharmacol; 2013 Sep; 84(3):407-14. PubMed ID: 23793290
[TBL] [Abstract][Full Text] [Related]
31. Oxidative inhibition of the mitochondrial aldehyde dehydrogenase promotes nitroglycerin tolerance in human blood vessels.
Hink U; Daiber A; Kayhan N; Trischler J; Kraatz C; Oelze M; Mollnau H; Wenzel P; Vahl CF; Ho KK; Weiner H; Munzel T
J Am Coll Cardiol; 2007 Dec; 50(23):2226-32. PubMed ID: 18061070
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the action of nitric oxide prodrugs by pyocyanin: mechanistic studies.
Hussain AS; Bozinovski J; Maurice DH; McLaughlin BE; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 1997 May; 75(5):398-406. PubMed ID: 9250373
[TBL] [Abstract][Full Text] [Related]
33. Vascular tolerance to nitroglycerin in ascorbate deficiency.
Wölkart G; Wenzl MV; Beretta M; Stessel H; Schmidt K; Mayer B
Cardiovasc Res; 2008 Jul; 79(2):304-12. PubMed ID: 18442986
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial nitrite reduction coupled to soluble guanylate cyclase activation: lack of evidence for a role in the bioactivation of nitroglycerin.
Kollau A; Beretta M; Russwurm M; Koesling D; Keung WM; Schmidt K; Mayer B
Nitric Oxide; 2009 Feb; 20(1):53-60. PubMed ID: 18951990
[TBL] [Abstract][Full Text] [Related]
35. Site-directed mutagenesis of aldehyde dehydrogenase-2 suggests three distinct pathways of nitroglycerin biotransformation.
Wenzl MV; Beretta M; Griesberger M; Russwurm M; Koesling D; Schmidt K; Mayer B; Gorren AC
Mol Pharmacol; 2011 Aug; 80(2):258-66. PubMed ID: 21536753
[TBL] [Abstract][Full Text] [Related]
36. Glyceryl trinitrate-induced desensitization of guanylate cyclase in cultured rat lung fibroblasts.
Schröder H; Leitman DC; Bennett BM; Waldman SA; Murad F
J Pharmacol Exp Ther; 1988 May; 245(2):413-8. PubMed ID: 2452870
[TBL] [Abstract][Full Text] [Related]
37. Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling.
Frederiksen LJ; Sullivan R; Maxwell LR; Macdonald-Goodfellow SK; Adams MA; Bennett BM; Siemens DR; Graham CH
Clin Cancer Res; 2007 Apr; 13(7):2199-206. PubMed ID: 17404104
[TBL] [Abstract][Full Text] [Related]
38. Changes in aldehyde dehydrogenase 2 expression in rat blood vessels during glyceryl trinitrate tolerance development and reversal.
D'Souza Y; Dowlatshahi S; Bennett BM
Br J Pharmacol; 2011 Sep; 164(2b):632-43. PubMed ID: 21506955
[TBL] [Abstract][Full Text] [Related]
39. Heterozygous deficiency of manganese superoxide dismutase in mice (Mn-SOD+/-): a novel approach to assess the role of oxidative stress for the development of nitrate tolerance.
Daiber A; Oelze M; Sulyok S; Coldewey M; Schulz E; Treiber N; Hink U; Mülsch A; Scharffetter-Kochanek K; Münzel T
Mol Pharmacol; 2005 Sep; 68(3):579-88. PubMed ID: 15933216
[TBL] [Abstract][Full Text] [Related]
40. Decrease in endogenous CGRP release in nitroglycerin tolerance: role of ALDH-2.
Chen YR; Nie SD; Shan W; Jiang DJ; Shi RZ; Zhou Z; Guo R; Zhang Z; Li YJ
Eur J Pharmacol; 2007 Sep; 571(1):44-50. PubMed ID: 17585900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
